September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Magnetic Hyperthermia Treatment in Y-79 Retinoblastoma and ARPE-19 RPE Cells: Concentration Dependent Effect of Iron Oxide Nanoparticle
Author Affiliations & Notes
  • Naziha Slimani
    kellogg eye center, Canton, Michigan, United States
  • Mercy D Pawar
    kellogg eye center, Canton, Michigan, United States
  • Zeynep Gursel Ozkurt
    kellogg eye center, Canton, Michigan, United States
  • Ronald Tucker
    kettering university, Flint, Michigan, United States
  • Prem Vaishnava
    kettering university, Flint, Michigan, United States
  • Cagri G Besirli
    kellogg eye center, Canton, Michigan, United States
  • Hakan Demirci
    kellogg eye center, Canton, Michigan, United States
  • Footnotes
    Commercial Relationships   Naziha Slimani, None; Mercy Pawar, None; Zeynep Gursel Ozkurt, None; Ronald Tucker, None; Prem Vaishnava, None; Cagri Besirli, None; Hakan Demirci, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3995. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Naziha Slimani, Mercy D Pawar, Zeynep Gursel Ozkurt, Ronald Tucker, Prem Vaishnava, Cagri G Besirli, Hakan Demirci; Magnetic Hyperthermia Treatment in Y-79 Retinoblastoma and ARPE-19 RPE Cells: Concentration Dependent Effect of Iron Oxide Nanoparticle. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3995.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the selective death of Y-79 retinoblastoma cells by using different concentrations of dextran-coated iron oxide nanoparticles in magnetic hyperthermia therapy.

Methods : Y-79 retinoblastoma and ARPE-19 control cells were incubated with dextran-coated iron oxide nanoparticles solution at 500 μg/ml, 750 μg/ml and 1000 μg/ml. The cells were then subjected to magnetic field for 20 minutes at 45 to 46 degrees Celcius. The temperature was measured using a fiber optic thermometer. Cell Viability analysis was done using CellTiter-Glo Luminescent Assay after 4 hr and 24 hr of treatment. cells without nanoparticles and with nanoparticles not subjected to magnetic hyperthermia treatment were used as controls. The pH of nenoparticles solutions was also recorded

Results : No cytotoxicity-associated death due to pH of the nanoparticles solution was observed. Following magnetic hyperthermia therapy by using iron oxide nanoparticles at the concentration 750μg/ml, cell viability of Y-79 cells was of 94% at 4 hr and 38% at 24 hr.
Viability for Y-79 cells was 99.5% and 60% at 4 and 24 hours respectively fo 500 μg/ml nanoparticle solution. No significant cell death was measured in ARPE-19 control group with either concentration of nanoparticle solution. Magnetic hyperthermia treatment in the absence of iron oxide nanoparticles did not induce cell death. Non-specific cytotoxicity of iron oxide nanoparticle solution was seen at 24 hours in cells exposed to 1000 μg/ml concentration.

Conclusions : Our results demonstrate that magnetic hyperthermia using iron oxide nanoparticles lead to selective death in retinoblastoma cells.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×